AVAC is the only pharmaceutical firm producing a Vaccine.
The Demand Curve for its product is Qd = 250 – 50 P
where P is Price and Q are packs of vaccines in ‘000
Total Cost Function estimated by the firm is TC = 15 + 0.5Q
where Q is monthly output.
a. What is the market structure of AVAC? State its characteristics.
b. To maximize profit,
(i) What will be the optimum price and how many packs of Vaccine should the firm produce and sell per month?
(ii) If this number of packs is produced and sold, what will be the firm’s monthly profit?
c. Using available information, draw AVAC’s demand, marginal revenue and marginal cost curves in a graph and clearly label thefirm’s profit maximizing price, quantity and profit. Do you observe any welfare loss? If so, also indicate and label the area on the graph.
d. Assume all other pharmaceutical firms in the market start producing the Vaccine and the market becomes competitive. What will be the impact on price and marginal revenue?Would the market structure of the firm remain the same? Support your answer with help of the firm’s graph.
Qd = 250 – 50P, or P = 5 - 0.02Q.
a. The market structure of AVAC is monopoly, because it is the only producer in the market.
b. To maximize profit,
(i) the optimum price and quantity of Vaccine per month are:
MR = MC,
MR = TR'(Q) = 5 - 0.04Q,
MC = TC'(Q) = 0.5.
5 - 0.04Q = 0.5,
0.04Q = 4.5,
Q = 112.5 units,
P = 5 - 0.02*112.5 = 2.75.
(ii) If this number of packs is produced and sold, then the firm’s monthly profit is:
"TP = 2.75*112.5 - (15 + 0.5*112.5) = 238.125."
c. There is a welfare loss in the monopoly market.
d. If all other pharmaceutical firms in the market start producing the Vaccine and the market becomes competitive, then the price and marginal revenue will decrease, and the market structure of the firm will become competitive.
Comments
Leave a comment